PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-03-03

Date Title Company
03-Mar-2026 Nature Made® Continues Expansion of its Gut Health Offerings with the Launch of SuperGreens and Digestive Enzymes Businesswire
03-Mar-2026 Oncodesign Precision Medicine Receives Support from The Michael J. Fox Foundation to Advance Development of LRRK2 Inhibitor OPM-201 for Parkinson’s Disease Businesswire
03-Mar-2026 IMPLANET Receives FDA Clearance in the United States for the 3D Cage Range – Swingo™ Businesswire
03-Mar-2026 Forma Life Sciences Launches U.S. Based Contract Development and Manufacturing Organization (CDMO) for Oral Solid Dosage Development and Commercial Manufacturing in Irvine, California Businesswire
03-Mar-2026 Flo Health Publishes Groundbreaking Research on Economic Impact of Digital Tools for Endometriosis Care ACCESS Newswire
03-Mar-2026 Moses Singer Welcomes Litigation Partner Jessica Caterina Businesswire
03-Mar-2026 Mobile Heartbeat's Banyan Platform Connects Health System Staff Across the Enterprise Through Microsoft Teams Businesswire
03-Mar-2026 Parnell Launches Pentobarbital Sodium and Phenytoin Sodium Euthanasia Solution for Dogs Businesswire
03-Mar-2026 Propel Software Marks Best Year in Company History Fueled by DesignHub, Propel One Solutions Businesswire
03-Mar-2026 Axcend, MassTech Deliver Compact LC–MS Solution for Trace-Level Detection at Point of Need Businesswire
03-Mar-2026 Demeetra Publication in Biotechnology Progress Validates Integrated Platforms for Commercial Cell Line Development Businesswire
03-Mar-2026 Camgenium Expands NHS Access to Advanced, Risk-Adjusted Clinical Audit Analytics Camgenium
03-Mar-2026 bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients Businesswire
03-Mar-2026 Moderna Resolves Global Patent Litigation with Arbutus/Genevant ACCESS Newswire
03-Mar-2026 Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel Businesswire
03-Mar-2026 Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders Businesswire
03-Mar-2026 Konovo Names Jessica Santos as Chief Compliance and Privacy Officer Businesswire
03-Mar-2026 Antiverse Raises $9.3M Series A to Develop Antibodies for Undruggable Disease Targets and Announces Research Agreement with the Cystic Fibrosis Foundation Businesswire
03-Mar-2026 NorthSea Therapeutics Announces Achievement of Key Regulatory Milestones for Orziloben Businesswire
03-Mar-2026 Syntis Bio Announces First Patient Dosed in Phase 1/1b Clinical Trial of SYNT-101 in Obesity and Key Leadership Additions Businesswire